Advisory on Costly Drug
- Share via
I certainly agree with an Aug. 1 letter writer that the cost of pharmaceutical companies’ commercials--to say nothing of their lobbying costs--increases the cost of drugs many times over. However, in this case maybe the writer should consider herself lucky, since the FDA has issued a health advisory on Lamisil tablets after being made aware of 16 cases of liver failure (including 11 deaths) possibly associated with the drug.
Lucille Whalen
Los Angeles